BMX (bone marrow kinase on chromosome X) is a cytosolic non-receptor tyrosine kinase of the TEC family that functions as a central regulator of diverse signaling pathways. Primary functions include modulation of actin reorganization, cell migration, proliferation, survival, and apoptosis through signal transduction downstream of growth factor receptors, cytokine receptors, and integrins 1. BMX mechanistically activates critical signaling cascades including JAK-STAT and NF-κB pathways; it phosphorylates STAT3 and regulates IL-6-induced differentiation, with its activity dependent on pleckstrin homology domain-mediated membrane localization 12. Beyond immune regulation, BMX participates in TNF-induced angiogenesis and ischemic response in cardiac tissue 1. Disease relevance spans inflammation, where BMX regulates pro-inflammatory cytokine secretion and contributes to arthritis pathogenesis, and cancer, where elevated BMX expression promotes adenoma initiation in colorectal cancer through polyp-like epithelial proliferation and supports glioblastoma stem cell maintenance and radioresistance via USP4-mediated STAT3 activation 23. BMX also functions as a PANoptosis-related gene with diagnostic potential in spinal cord injury, correlating with immune cell infiltration and inflammatory response 4. Clinically, BMX represents a therapeutic target for cancer treatment, with kinase inhibitors showing promise in glioblastoma, prostate, breast, and lung cancers 5.